{"log_id": 4614583924048065416, "direction": 0, "words_result_num": 55, "words_result": [{"probability": {"variance": 0.010819, "average": 0.948641, "min": 0.534857}, "location": {"width": 664, "top": 149, "height": 42, "left": 257}, "words": "以脱离输注红细胞和血小板。反应标准见表4:"}, {"probability": {"variance": 0.005547, "average": 0.950615, "min": 0.767618}, "location": {"width": 400, "top": 239, "height": 38, "left": 644}, "words": "表4II期临床试验反应标准"}, {"probability": {"variance": 0.011586, "average": 0.941384, "min": 0.594609}, "location": {"width": 644, "top": 277, "height": 35, "left": 257}, "words": "完全缓解(CR)≥8周骨髓熏复骨髓涂片"}, {"probability": {"variance": 0.00203, "average": 0.978828, "min": 0.86072}, "location": {"width": 199, "top": 315, "height": 35, "left": 753}, "words": "原始粒细胞<5%"}, {"probability": {"variance": 0.01787, "average": 0.921945, "min": 0.552685}, "location": {"width": 416, "top": 355, "height": 38, "left": 756}, "words": "无造血细胞发育异常(病态造血)"}, {"probability": {"variance": 0.004492, "average": 0.953315, "min": 0.819625}, "location": {"width": 351, "top": 389, "height": 40, "left": 606}, "words": "外周血缓懈相间所有血样"}, {"probability": {"variance": 0.026971, "average": 0.910149, "min": 0.411454}, "location": {"width": 565, "top": 431, "height": 35, "left": 756}, "words": "Hg>11g/dL(未输血或使用促红细胞生成素〕"}, {"probability": {"variance": 0.008076, "average": 0.929558, "min": 0.669784}, "location": {"width": 418, "top": 469, "height": 33, "left": 756}, "words": "ANC≥1500/L(未使用生长医子)"}, {"probability": {"variance": 0.022483, "average": 0.937278, "min": 0.390636}, "location": {"width": 539, "top": 505, "height": 35, "left": 753}, "words": "血小板二10万/L(未使用促小板生成药)"}, {"probability": {"variance": 0.000227, "average": 0.991118, "min": 0.957366}, "location": {"width": 344, "top": 543, "height": 35, "left": 751}, "words": "无原始细胞或发育异常情况"}, {"probability": {"variance": 0.024319, "average": 0.911838, "min": 0.402005}, "location": {"width": 646, "top": 579, "height": 40, "left": 257}, "words": "部分线解(PR)≥8周骨髓重复骨髓片"}, {"probability": {"variance": 1.2e-05, "average": 0.997533, "min": 0.992692}, "location": {"width": 82, "top": 624, "height": 29, "left": 756}, "words": "与治疗"}, {"probability": {"variance": 0.021571, "average": 0.873384, "min": 0.570906}, "location": {"width": 536, "top": 597, "height": 76, "left": 838}, "words": "前比,原始细胞下降0%控多"}, {"probability": {"variance": 0, "average": 0.996191, "min": 0.996191}, "location": {"width": 35, "top": 659, "height": 33, "left": 722}, "words": "或"}, {"probability": {"variance": 0.006103, "average": 0.950109, "min": 0.687948}, "location": {"width": 657, "top": 695, "height": 40, "left": 751}, "words": "按FAB分类标,疾病改善到MDS后较好的型"}, {"probability": {"variance": 0.00012, "average": 0.990609, "min": 0.9685}, "location": {"width": 196, "top": 731, "height": 38, "left": 606}, "words": "外周血同CR"}, {"probability": {"variance": 0.012743, "average": 0.866364, "min": 0.620519}, "location": {"width": 1026, "top": 769, "height": 38, "left": 279}, "words": " Cheson BD, Bennett M, et al. Report of an International Working Group to Standardize"}, {"probability": {"variance": 0.004282, "average": 0.969885, "min": 0.79646}, "location": {"width": 532, "top": 807, "height": 26, "left": 272}, "words": " Criteria fcr MDS. Blood. 2000: 95:3671-3574"}, {"probability": {"variance": 0.016492, "average": 0.942898, "min": 0.469171}, "location": {"width": 1187, "top": 872, "height": 46, "left": 201}, "words": "地西他滨治疗组r人群的总缓解率(完全缓解+部分缓解)为17%,支持"}, {"probability": {"variance": 0.003566, "average": 0.974144, "min": 0.69083}, "location": {"width": 1129, "top": 919, "height": 40, "left": 254}, "words": "治疗组为0%(p0.001)(见表5)。地西滨治疗组可评估患者的总有效率为21%"}, {"probability": {"variance": 0.004799, "average": 0.974583, "min": 0.618963}, "location": {"width": 1075, "top": 964, "height": 40, "left": 270}, "words": "(1256)(即在基线时病埋检查证实MDS并至少接受了两个周期治疗的思者"}, {"probability": {"variance": 0.016049, "average": 0.93855, "min": 0.514879}, "location": {"width": 1178, "top": 1002, "height": 53, "left": 252}, "words": "地西他滨治疗有效患者的中位临床缓解持续时间为288天(116~38天斗念"}, {"probability": {"variance": 0.020355, "average": 0.922585, "min": 0.422143}, "location": {"width": 1207, "top": 1049, "height": 42, "left": 250}, "words": "起效时间为93天(55~272天)。除地西他滨治疗组1例患者外,所患者都在"}, {"probability": {"variance": 0.010858, "average": 0.95013, "min": 0.563404}, "location": {"width": 1207, "top": 1089, "height": 46, "left": 250}, "words": "第四周期末进行了疗效评估地西他滨组另有13%的患者观察到血液学的临床获"}, {"probability": {"variance": 0.005692, "average": 0.967359, "min": 0.642718}, "location": {"width": 1134, "top": 1134, "height": 40, "left": 250}, "words": "益(反应未达到部分缓解标准,持续至少8周),而支持治疗组为7%。与支持"}, {"probability": {"variance": 0.008151, "average": 0.971395, "min": 0.543915}, "location": {"width": 1033, "top": 1176, "height": 44, "left": 246}, "words": "疗组比,地西他滨治疗并不能显著延长进到AML或死亡的时间"}, {"probability": {"variance": 0.033818, "average": 0.895321, "min": 0.462736}, "location": {"width": 277, "top": 1252, "height": 38, "left": 686}, "words": "表5疗效分析(T"}, {"probability": {"variance": 0.000275, "average": 0.977231, "min": 0.960648}, "location": {"width": 60, "top": 1292, "height": 35, "left": 252}, "words": "参数"}, {"probability": {"variance": 0.037485, "average": 0.899017, "min": 0.376311}, "location": {"width": 503, "top": 1290, "height": 38, "left": 887}, "words": "地西他滨组N=9支持治疗组N81"}, {"probability": {"variance": 0.00062, "average": 0.978809, "min": 0.918297}, "location": {"width": 259, "top": 1335, "height": 33, "left": 252}, "words": "总缓解率(CR+R)"}, {"probability": {"variance": 0.000325, "average": 0.985115, "min": 0.946541}, "location": {"width": 127, "top": 1335, "height": 29, "left": 912}, "words": "15(17%)"}, {"probability": {"variance": 0.000253, "average": 0.982067, "min": 0.963419}, "location": {"width": 107, "top": 1335, "height": 31, "left": 1225}, "words": "00%)"}, {"probability": {"variance": 3.8e-05, "average": 0.991387, "min": 0.98398}, "location": {"width": 118, "top": 1373, "height": 35, "left": 288}, "words": "完全缓解"}, {"probability": {"variance": 0.00036, "average": 0.974658, "min": 0.955492}, "location": {"width": 71, "top": 1375, "height": 24, "left": 966}, "words": "(9%)"}, {"probability": {"variance": 0.036134, "average": 0.677995, "min": 0.524062}, "location": {"width": 93, "top": 1375, "height": 38, "left": 1261}, "words": "C%)"}, {"probability": {"variance": 0.000143, "average": 0.992378, "min": 0.971671}, "location": {"width": 118, "top": 1411, "height": 33, "left": 288}, "words": "部分缓解"}, {"probability": {"variance": 0.002232, "average": 0.967291, "min": 0.873114}, "location": {"width": 100, "top": 1411, "height": 29, "left": 937}, "words": "7(8%)"}, {"probability": {"variance": 0.067513, "average": 0.781327, "min": 0.41602}, "location": {"width": 60, "top": 1411, "height": 26, "left": 1259}, "words": "0%"}, {"probability": {"variance": 6.4e-05, "average": 0.990028, "min": 0.97778}, "location": {"width": 174, "top": 1449, "height": 35, "left": 250}, "words": "缓解持续时间"}, {"probability": {"variance": 0.022413, "average": 0.907812, "min": 0.568161}, "location": {"width": 463, "top": 1482, "height": 42, "left": 288}, "words": "中位起效时间(CR+PR)天(范图"}, {"probability": {"variance": 0.00676, "average": 0.917843, "min": 0.739093}, "location": {"width": 172, "top": 1487, "height": 29, "left": 908}, "words": "93(55~2/2)"}, {"probability": {"variance": 0.019062, "average": 0.908925, "min": 0.500697}, "location": {"width": 514, "top": 1521, "height": 40, "left": 288}, "words": "中位缓解持续时间(CR+PR〕天(范围)"}, {"probability": {"variance": 0.018605, "average": 0.910737, "min": 0.582303}, "location": {"width": 194, "top": 1525, "height": 29, "left": 892}, "words": "288(116~388〕"}, {"probability": {"variance": 0.014076, "average": 0.951425, "min": 0.489189}, "location": {"width": 697, "top": 1561, "height": 46, "left": 259}, "words": "统计分析中,p≤0.024才具有统计学显著性意义"}, {"probability": {"variance": 0.016189, "average": 0.918647, "min": 0.560701}, "location": {"width": 823, "top": 1601, "height": 44, "left": 272}, "words": "双侧 Fisher's精确概率检验:地西他组vs支持治疗组信p001"}, {"probability": {"variance": 0.001389, "average": 0.986857, "min": 0.790672}, "location": {"width": 1082, "top": 1639, "height": 49, "left": 304}, "words": "所有达到CR或PR的忌者均应满足:在不使用生长因子时可脱离输注红细"}, {"probability": {"variance": 4e-06, "average": 0.997633, "min": 0.99478}, "location": {"width": 165, "top": 1690, "height": 38, "left": 246}, "words": "胞和血小板"}, {"probability": {"variance": 0.008095, "average": 0.961107, "min": 0.692384}, "location": {"width": 590, "top": 1726, "height": 51, "left": 304}, "words": "基线诊断为AML的总者亦出现临床缓解"}, {"probability": {"variance": 0.028496, "average": 0.910998, "min": 0.573484}, "location": {"width": 187, "top": 1816, "height": 40, "left": 241}, "words": "2单组研究"}, {"probability": {"variance": 0.009344, "average": 0.965408, "min": 0.484853}, "location": {"width": 1084, "top": 1852, "height": 46, "left": 301}, "words": "进行了三项开放、单组、多中心研究,评价了地西他滨在治疗三AB分类中"}, {"probability": {"variance": 0.004018, "average": 0.971747, "min": 0.704298}, "location": {"width": 1140, "top": 1894, "height": 46, "left": 243}, "words": "所有亚型MDS患者的安全性和有效性。在北美进行的一项研究中,按IPSS分"}, {"probability": {"variance": 0.005405, "average": 0.970957, "min": 0.618382}, "location": {"width": 1116, "top": 1939, "height": 46, "left": 241}, "words": "为中危-1,中危2,高危的99例患者接受地西他滨治疗,给约剂量为20mg/m"}, {"probability": {"variance": 0.012677, "average": 0.954502, "min": 0.548946}, "location": {"width": 1149, "top": 1984, "height": 42, "left": 241}, "words": "连续静脉输注1小时,每天一次,连续5天,每4周重复…个周期。该研究结果"}, {"probability": {"variance": 0.003377, "average": 0.98018, "min": 0.779336}, "location": {"width": 431, "top": 2030, "height": 35, "left": 243}, "words": "与对照试验结果一致,见表6"}, {"probability": {"variance": 0.014216, "average": 0.911349, "min": 0.707227}, "location": {"width": 82, "top": 2145, "height": 26, "left": 1391}, "words": "地西-2"}], "language": 3}